These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3413127)

  • 41. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
    Robey WG; Arthur LO; Matthews TJ; Langlois A; Copeland TD; Lerche NW; Oroszlan S; Bolognesi DP; Gilden RV; Fischinger PJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7023-7. PubMed ID: 3018753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus.
    Joag SV; Li Z; Wang C; Foresman L; Jia F; Stephens EB; Zhuge W; Narayan O
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):391-4. PubMed ID: 10082123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution and quantification of human immunodeficiency virus type 1, strain JC499, proviral DNA in tissues from an infected chimpanzee.
    Wei Q; Javadian A; Lausen N; Fultz PN
    Virology; 2000 Oct; 276(1):59-69. PubMed ID: 11021995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.
    Robinson WE; Montefiori DC; Mitchell WM
    Biochem Biophys Res Commun; 1987 Dec; 149(2):693-9. PubMed ID: 3426595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rectal transmission of human immunodeficiency virus type 1 to chimpanzees.
    Fultz PN; Wei Q; Yue L
    J Infect Dis; 1999 May; 179 Suppl 3():S418-21. PubMed ID: 10099110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.
    Goudsmit J; Smit L; Klaver B; Asher DM; Wolff A; Gibbs CJ; Gajdusek DC
    Viral Immunol; 1987-1988; 1(3):225-40. PubMed ID: 3509947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
    Neurath AR; Jiang S; Strick N; Kolbe H; Kieny MP; Muchmore E; Girard M
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):813-23. PubMed ID: 1720628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization.
    Castro BA; Walker CM; Tateno M; Cheng-Mayer C; Heberling R; Eichberg JW; Levy JA
    J Med Primatol; 1989; 18(3-4):337-42. PubMed ID: 2760917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stages in the progression of HIV infection in chimpanzees.
    Saxinger C; Alter HJ; Eichberg JW; Fauci AS; Robey WG; Gallo RC
    AIDS Res Hum Retroviruses; 1987; 3(4):375-85. PubMed ID: 3482160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospects for an AIDS vaccine.
    Girard M
    Cancer Detect Prev; 1990; 14(3):411-3. PubMed ID: 2117487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of an immunoglobulin preparation from HIV carriers in preventing HIV replication in vitro.
    Tochikura TS; Nakashima H; Uemura Y; Goto T; Suyama T; Kobayashi N; Yamamoto N
    Vox Sang; 1988; 54(3):138-43. PubMed ID: 3369135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immunodeficiency virus: an agent that defies vaccination.
    Nathanson N; Gonzalez-Scarano F
    Adv Vet Sci Comp Med; 1989; 33():397-412. PubMed ID: 2648777
    [No Abstract]   [Full Text] [Related]  

  • 57. Enhancement in the safety of immune globulins prepared from high-risk plasma.
    Gao F; Prince AM; Pascual D; Horowitz B
    Vox Sang; 1993; 64(4):204-9. PubMed ID: 8390765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Passive immunotherapy in AIDS: transfusion of plasma rich in anti-p25 antibody (phase I trial)].
    Lefrère JJ; Vittecoq D; Mattlinger B; Boulard G; de Bruyn B; Couroucé AM; Rouzioux C; Doinel C; Bary M; Salmon C
    Rev Fr Transfus Hemobiol; 1991 May; 34(3):199-211. PubMed ID: 2064687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential use of serotherapy in the prevention and treatment of infection with the human immunodeficiency virus.
    Zolla-Pazner S; Pinter A; Mizuma H
    J Virol Methods; 1987 Aug; 17(1-2):45-53. PubMed ID: 3312267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermal inactivation of human immunodeficiency virus in lyophilised blood products evaluated by ID50 titrations.
    Tersmette M; de Goede RE; Over J; de Jonge E; Radema H; Lucas CJ; Huisman HG; Miedema F
    Vox Sang; 1986; 51(3):239-43. PubMed ID: 3643679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.